- Home
- ICON vs SCNI Comparison
ICON vs SCNI Comparison
Compare ICON & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ICON | SCNI |
|---|---|---|
| Founded | 2023 | 2003 |
| Country | Greece | Israel |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7M | 4.6M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | ICON | SCNI |
|---|---|---|
| Price | $0.66 | $0.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 146.8K | 62.8K |
| Earning Date | 04-02-2026 | 03-27-2026 |
| Dividend Yield | ★ 1363.31% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $9,449,000.00 | $1,147,000.00 |
| Revenue This Year | $128.63 | N/A |
| Revenue Next Year | $10.92 | N/A |
| P/E Ratio | ★ N/A | $2.47 |
| Revenue Growth | 96.44 | ★ 303.87 |
| 52 Week Low | $0.55 | $0.61 |
| 52 Week High | $93.19 | $6.18 |
Technical Indicators
Market Signals| Indicator | ICON | SCNI |
|---|---|---|
| Relative Strength Index (RSI) | 35.92 | 36.53 |
| Support Level | $0.55 | $0.61 |
| Resistance Level | $0.77 | $0.80 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 39.29 | 18.81 |
Price Performance
Historical ComparisonAbout ICON Icon Energy Corp.
Icon Energy Corp is a growth-oriented shipping company providing seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels. The company generates its revenues by chartering its vessels to regional and international dry bulk operators, commodity traders and end users.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.